A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+20.28%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$134M
AUM Growth
+$134M
(+12%)
Cap. Flow
+$3.65M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
93.35%
Holding
19
New
2
Increased
1
Reduced
1
Closed
2
Top Buys
1 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$3.83M |
2 |
Aurinia Pharmaceuticals
AUPH
|
$1.85M |
3 |
IMDZ
Immune Design Corp.
IMDZ
|
$1.05M |
Top Sells
1 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$1.17M |
2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$973K |
3 |
NOVN
Novan, Inc. Common Stock
NOVN
|
$926K |
Sector Composition
1 | Healthcare | 93.75% |
2 | Technology | 0.69% |